EpiLight Truly Destroys Hair Follicles!

New scientific data demonstrates that EpiLight proprietary intense pulsed light (IPL) technology uniquely achieves significant long-lasting hair removal via genuine and selective cell destruction to hair follicles. This is quite different from the mechanisms of action reported with laser devices that induce a transient rest cycle or follicular miniaturization.

First Independent Peer Reviewed Study of EpiLight Results

This is the first independent and peer reviewed published study that examines the clinical, histological and mechanistic effects in skin of the EpiLight hair removal method (Archives of Dermatology, Vol 135, June 1999). According to the investigators at New York Hospital-Cornell Medical Center and Duke University Medical Center, the objective of the study was to look not only at clinical findings, but more importantly to evaluate morphologic changes occurring at the cell or tissue level, and to access the involvement of well-known proteins in the cell cycle. Using this comprehensive approach, experts can better identify the specific changes associated with effective hair removal and achieve a better therapeutic outcome.

Clinical Efficacy of Intense Pulsed Light (IPL)

"There are many light-based technologies available today for removing undesired hair, yet the precise mechanisms for stopping hair growth remain unclear," said New York dermatologist and assistant professor at Cornell University, Neil S. Sadick, MD, the lead author of the study. "We want to demonstrate that unlike laser systems for hair removal, EpiLight therapy produces a frank destruction of hair follicles, rather than simply inducing temporary and subtle alterations to the hair cycle and follicles." The IPL instrument used in this investigation differs from laser technologies in that it is a noncoherent, broad band spectrum, visible near infrared light source. These features lend EpiLight its superior clinical efficacy, low side effects profile and high degree of tissue selectivity, with thermal damage mostly confined to targeted hair follicles.

In patients who received a single treatment, there was a mean hair loss of 48% at follow-up of 6 months or more. In subjects who received multiple treatments there was a mean hair loss of 64% at follow-up of 6 months or more.

	No pigmentary or scarring complications developed in any subject.
	Treatments were well tolerated and without serious adverse side effects.
	Histological findings showed no significant hair regrowth up to 20 months after treatment.
	No morphologic alterations were identified in other skin adnexa, overlying epidermis, vessels or other dermal structures.
	Unirradiated control skin showed normal appearing of hair follicles.

LaseHair Hair Removal Centre
1703 S. 324th St., Suite B Federal Way, WA 98003
Email: lasehair@yahoo.com
(253) 838- 4889     (877) 927- 4247

Site Designed by: Adstar Web Media